Substituted oxazolidinones and their use in the field of blood coagulation

US8129378B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Alexander Straub · Wuppertal, DE
• Thomas Lampe · Mülheim an der Ruhr, DE
• Jens Pohlmann · Basel, CH
• Susanne Röhrig · Hilden, DE
• Elisabeth Perzborn · Wuppertal, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Joseph Pernerstorfer · Wuppertal, DE

Key dates

• Filing date: Jun 30, 2009
• Grant date: Mar 6, 2012
• Expiry date: Jun 30, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D495/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the field of blood coagulation. Novel oxazolidinone derivatives of the general formula (I)processes for their preparation and their use as medicinally active compounds for the prophylaxis and/or treatment of disorders are described.